会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • 2,4-diaminopyrimidine derivatives
    • 2,4-二氨基嘧啶衍生物
    • US06395742B1
    • 2002-05-28
    • US09667458
    • 2000-09-22
    • Jean-Paul René Marie André BosmansChristopher John LoveGuy Rosalia Eugène Van Lommen
    • Jean-Paul René Marie André BosmansChristopher John LoveGuy Rosalia Eugène Van Lommen
    • C07D40112
    • C07D401/12C07D401/14C07D405/14
    • The present invention concerns the compounds of formula the N-oxide forms, the pharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof, wherein Alk is C1-6alkanediyl or C3-6alkenediyl; R1 is hydrogen or C1-4alkyl; R2 and R3 each independently are hydrogen, C1-6alkyl or C3-7cycloalkyl; or R2 and R3 may also be taken together with the nitrogen atom to which they are attached, thus forming a pyrrolidine, a piperidine or a perhydro azepine ring; R4 is hydrogen or halo; Q is aryl, aryloxy, di(aryl)methyl or heteroaryl; aryl is naphthyl or phenyl, said naphthyl and phenyl may optionally be substituted; and heteroaryl is quinolinyl, isoquinolinyl, pyridinyl, thienyl, indolyl, 2,3-dihydro-1,4-benzodioxinyl, 2,3-dihydro-benzofuranyl or benzodioxolanyl; said heteroaryls may optionally be substituted; it further relates to processes for their preparation, compositions comprising them as well as their use as a medicine; compounds of formula (I) containing a radioactive isotope; a process of marking dopamine D4 receptor sites; and a process for imaging an organ are disclosed.
    • 本发明涉及配制N-氧化物形式的化合物,其药学上可接受的酸加成盐和立体化学异构形式,其中Alk是C 1-6烷二基或C 3-6亚烯基; R1是氢或C1-4烷基; R2和R3各自独立地为氢,C1-6烷基或C3-7环烷基; 或者R 2和R 3也可以与它们所连接的氮原子一起,从而形成吡咯烷,哌啶或全氢吖庚因环; R4是氢或卤素; Q是芳基,芳氧基,二(芳基)甲基或杂芳基; 芳基是萘基或苯基,所述萘基和苯基可任选被取代; 异喹啉基,吡啶基,噻吩基,吲哚基,2,3-二氢-1,4-苯并二氧杂环戊烯基,2,3-二氢 - 苯并呋喃基或苯并二氧杂环戊烷基; 所述杂芳基可任选被取代; 它还涉及它们的制备方法,包含它们的组合物以及它们作为药物的用途; 含有放射性同位素的式(I)化合物; 标记多巴胺D4受体位点的过程; 并且公开了用于成像器官的方法。